期刊文献+

志贺菌属菌群及血清型18年的变化趋势与耐药性 被引量:6

Distribution and antimicrobial resistant tendency of Shigella spp.group and serotype in diarrhea patients during 18 years
原文传递
导出
摘要 目的监测医院1992-2009年与腹泻有关志贺菌属菌群及血清型18年的变化和耐药趋势,为北京地区的流行病学研究、疫苗的制备及临床合理用药提供依据。方法通过便培养,致病菌经生化及血清学进一步鉴定到种、群或血清型,并以纸片扩散法测定了抗菌药物的敏感性。结果 18年分离出志贺菌属6745株,包括志贺菌属的4个群27个血清型,B群最多占72.0%;D群占27.3%,有明显增多的趋势;福氏志贺菌F2a、F1a分别占73.3%、4.0%;不同菌群对抗菌药物的敏感率有差异,B群多药耐药较多。结论志贺菌属菌群及血清型种类多,随时间的变迁变化明显,耐药性不同,应重视监测并指导防治。 OBJECTIVE To monitor the constitutes and resistant tendency of Shigella spp.group and serotype in diarrheal patients in hospital from 1992 to 2009,to offer the date for guiding epidemiologic study,vaccination research and clinical treatment.METHODS The pathogens cultured from feces had been cultured and identified to family,genus and serotype,then the susceptibility of Shigella to antimicrobial agents was tested by disc diffusion method.RESULTS A total of 6777 isolates were identified during 18 years.Shigella spp.B group(71.7%) was the most frequently pathogens,followed by D group(27.2%).Serotype F2a and F1a(73.3% and 4.0%) respectively.The sensitive rate of differential group to differential antimicrobial agents is unlikeness.S.flexneri showed higher resistant rate to most of antibiotics.CONCLUSION It should attach great importance to monitor the various groups and serotypes of the Shigella spp,whose drug resistance have changed significantly.
机构地区 解放军
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第16期3526-3528,共3页 Chinese Journal of Nosocomiology
关键词 志贺菌属 菌群 血清型 分布 耐药性 Shigella spp. Group Serotype Distribution Drug resistance
  • 相关文献

参考文献8

  • 1Sharma A,Kumar S,Kori L. Molecular Epidemiological Char- acteristics of Shigella spp Isolated from River Narmada During 2005--2006[J]. J Environ Health,2009,71(6):61-66.
  • 2CLSI. Performance standards for antimicrobial disk suscepti bility tests: Approved standard[S], 10th ed. Wayne, PA:Clinical and Laboratory Standards Institute, 2008.
  • 3Salmanzadeh-Ahrabi S, Jafari F, Habibi E, et al. Serotype dis tribution and antimicrobial resistance rates of Shigella spp. i solates in Tehran, Iran[J]. Mikrobiyol Bul,2007,41(3) :453-457.
  • 4Orrett FA. Prevalence of Shigella serogroups and their antimi- crobial resistance patterns in southern Trinidadv[J]. J Health Popul Nutr,2008,26(4) :456-462.
  • 5Bangtrakulnonth A, Vieira AR, Wong DM, et al. Shigella from humans in Thailand during 1993 to 2006: spatial-time trends in species and serotype distribution [J]. Foodborne Pathog Dis,2008,5(6) :773-784.
  • 6曲芬,毛远丽,崔恩博,郭桐生,鲍春梅,刘立明,李筱涵,李波.北京地区1994—2005年腹泻病原菌的分布及其耐药趋势[J].中华内科杂志,2008,47(4):304-307. 被引量:27
  • 7Wei HL,Wang YW, Li CC,et al. Epidemiology and evolution of genotype and antimicrobial resistance of an imported Shigel- la sonnei clone circulating in central Taiwan[J]. Diagn Micro- biol Infect Dis, 2007,58 (4) : 469-475.
  • 8Nagano Y, Nagano N, Wachino. Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lac- tamases, found in a Shigella sonnei strain resistant to various oxy- imino-cephalosporins, including ceftazidime [ J ]. Antimicrob Agents Chemother, 2009,53 (1) : 69-74.

二级参考文献10

  • 1Kotloff KL, Noriega FR, Samandari T, et al. Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans. Infect Immun, 2000,68: 1034-1039.
  • 2Kotloff KL, Nataro JP, Losonsky GA, et al. A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity. Vaccine, 1995,13 : 1488-1494.
  • 3Noriega FR, Liao FM, Maneval DR, et al. Strategy for cross-protection among Shigella flexneri serotypes. Infect Immun, 1999, 67:782-788.
  • 4Chompook P, Todd J, Wheeler JG, et al. Risk factors for shigellosis in Thailand. Int J Infect Dis,2006,10:425-433.
  • 5Kotloff KL, Winickoff JP, Ivanoff B, et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ, 1999,77 : 651-666.
  • 6von Seidlein L, Kim DR, Ali M, et al. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med, 2006, 3 : e353.
  • 7Sivapalasingam S, Nelson JM, Joyee K, et al. High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. Antimicrob Agents Chemother, 2006,50:49- 54.
  • 8Ozmert EN, Gokturk B, Yurdakok K, et al. Shigella antibiotic resistance in central Turkey: comparison of the years 1987-1994 and 1995-2002. J Pediatr Gastroenterol Nutr, 2005, 40:359-362.
  • 9Dutta S, Rajendran K, Roy S, et al. Shifting serotypes, plasmid profile analysis and antimicrobial resistance pattern of shigellae strains isolated from Kolkata, India during 1995 -2000. Epidemiol Infect, 2002,129:235-243.
  • 10Fulla N, Prado V, Duran C, et al. Surveillance for antimicrobial resistance profiles among Shigella species isolated from a semirural community in the northern administrative area of Santiago, Chile. Am J Trop Med Hyg, 2005,72:851-854.

共引文献26

同被引文献68

引证文献6

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部